Legend Biotech Announces Phase 3 CARTITUDE-4 Study of CARVYKTI..
Jan 27, 2023
Legend Biotech Announces Notification of Delinquency from The Nasda..
Jan 10, 2023
Legend Biotech to Participate in the 41st Annual JP Morgan Healthca..
Jan 04, 2023
Legend Biotech Announces Acceptance of Its New Drug Application for..
Jan 02, 2023
Legend Biotech Announces FDA Clearance of IND Application for LB210..
Nov 21, 2022